Cargando…
The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease
There is a now a wealth of epidemiological, animal, and clinical data to suggest the benefits of uric acid reduction and hxanthine oxidase inhibition in prevention of vascular disease. This review discusses the available epidemiological, preclinical, and clinical data and considers arguments for and...
Autores principales: | Higgins, Peter, Dawson, Jesse, Walters, Matthew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790135/ https://www.ncbi.nlm.nih.gov/pubmed/20029618 http://dx.doi.org/10.1155/2009/282059 |
Ejemplares similares
-
Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta‐analysis
por: Zhang, Jufen, et al.
Publicado: (2016) -
Effect of Xanthine Oxidase Inhibition on Arterial Stiffness in Patients With Chronic Heart Failure
por: Alem, Manal M, et al.
Publicado: (2018) -
Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
por: Saito, Hirotaka, et al.
Publicado: (2021) -
Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk
por: Feaver, Ryan E., et al.
Publicado: (2023) -
Xanthine oxidase inhibitors and sepsis
por: Ramos, Maria Fátima de Paula, et al.
Publicado: (2018)